Poussin MA - Search Results

1

Induction of myasthenia gravis in HLA transgenic mice by immunization with human acetylcholine receptors.

Yang H, Goluszko E, David C, Okita DK, Conti-Fine B, Chan TS, Poussin MA, Christadoss P. Yang H, et al. Among authors: poussin ma. Ann N Y Acad Sci. 2003 Sep;998:375-8. doi: 10.1196/annals.1254.044. Ann N Y Acad Sci. 2003. PMID: 14592899

2

Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis.

Goluszko E, Deng C, Poussin MA, Christadoss P. Goluszko E, et al. Among authors: poussin ma. J Neuroimmunol. 2002 Jan;122(1-2):85-93. doi: 10.1016/s0165-5728(01)00474-x. J Neuroimmunol. 2002. PMID: 11777546

3

Mapping myasthenia gravis-associated T cell epitopes on human acetylcholine receptors in HLA transgenic mice.

Yang H, Goluszko E, David C, Okita DK, Conti-Fine B, Chan TS, Poussin MA, Christadoss P. Yang H, et al. Among authors: poussin ma. J Clin Invest. 2002 Apr;109(8):1111-20. doi: 10.1172/JCI14255. J Clin Invest. 2002. PMID: 11956249 Free PMC article.

4

Role of IL-5 during primary and secondary immune response to acetylcholine receptor.

Poussin MA, Goluszko E, Franco JU, Christadoss P. Poussin MA, et al. J Neuroimmunol. 2002 Apr;125(1-2):51-8. doi: 10.1016/s0165-5728(02)00030-9. J Neuroimmunol. 2002. PMID: 11960640

5

Suppressed clinical experimental autoimmune myasthenia gravis in bm12 mice is linked to reduced intracellular calcium mobilization and IL-10 and IFN-gamma release by acetylcholine receptor-specific T cells.

Poussin MA, Fuller CL, Goluszko E, Reyes VE, Braciale VL, Christadoss P. Poussin MA, et al. J Neuroimmunol. 2003 Jan;134(1-2):104-10. doi: 10.1016/s0165-5728(02)00425-3. J Neuroimmunol. 2003. PMID: 12507777

6

B7-1 costimulatory molecule is critical for the development of experimental autoimmune myasthenia gravis.

Poussin MA, Tüzün E, Goluszko E, Scott BG, Yang H, Franco JU, Christadoss P. Poussin MA, et al. J Immunol. 2003 Apr 15;170(8):4389-96. doi: 10.4049/jimmunol.170.8.4389. J Immunol. 2003. PMID: 12682276

7

Suppression of experimental autoimmune myasthenia gravis in IL-10 gene-disrupted mice is associated with reduced B cells and serum cytotoxicity on mouse cell line expressing AChR.

Poussin MA, Goluszko E, Hughes TK, Duchicella SI, Christadoss P. Poussin MA, et al. J Neuroimmunol. 2000 Nov 1;111(1-2):152-60. doi: 10.1016/s0165-5728(00)00385-4. J Neuroimmunol. 2000. PMID: 11063833

8

Lymphotoxin-alpha deficiency completely protects C57BL/6 mice from developing clinical experimental autoimmune myasthenia gravis.

Goluszko E, Hjelmström P, Deng C, Poussin MA, Ruddle NH, Christadoss P. Goluszko E, et al. Among authors: poussin ma. J Neuroimmunol. 2001 Feb 1;113(1):109-18. doi: 10.1016/s0165-5728(00)00420-3. J Neuroimmunol. 2001. PMID: 11137582

9

HLA-DQ6 transgenic mice resistance to experimental autoimmune myasthenia gravis is linked to reduced acetylcholine receptor-specific IFN-gamma, IL-2 and IL-10 production.

Poussin MA, Goluszko E, David CS, Franco JU, Christadoss P. Poussin MA, et al. J Autoimmun. 2001 Nov;17(3):175-80. doi: 10.1006/jaut.2001.0541. J Autoimmun. 2001. PMID: 11712854

10

Animal models of myasthenia gravis.

Christadoss P, Poussin M, Deng C. Christadoss P, et al. Clin Immunol. 2000 Feb;94(2):75-87. doi: 10.1006/clim.1999.4807. Clin Immunol. 2000. PMID: 10637092 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters